Nucleoside Metabolic Inhibitor [EPC]

274072 reported adverse events

Drugs of this class: FLUOROURACIL AZACITIDINE DECITABINE CAPECITABINE CYTARABINE NELARABINE CLOFARABINE (DAUNORUBICIN AND CYTARABINE) LIPOSOME AZACITIDINE FOR CEDAZURIDINE AND DECITABINE FLUOROURACIL CREAM, 0.5%

These side effects are most commonly reported by patients taking drugs of the Nucleoside Metabolic Inhibitor [EPC] class:

# Side effect Count
0 DIARRHOEA 24111
1 DEATH 19709
2 NAUSEA 17607
3 FEBRILE NEUTROPENIA 15661
4 OFF LABEL USE 15496
5 NEUTROPENIA 14507
6 DISEASE PROGRESSION 14282
7 VOMITING 13272
8 FATIGUE 12881
9 PYREXIA 12114
See all common reactions for Nucleoside Metabolic Inhibitor [EPC]

Drugs of the Nucleoside Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACUTE MYELOID LEUKAEMIA RECURRENT 1178 0.5482
1 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7563 0.3241
2 ARTERIOSPASM CORONARY 1172 0.2918
3 ACUTE MYELOID LEUKAEMIA 4251 0.2725
4 VENOOCCLUSIVE LIVER DISEASE 1168 0.2363
5 FEBRILE NEUTROPENIA 15661 0.2358
6 SKIN TOXICITY 1315 0.2325
7 MUCOSAL INFLAMMATION 5782 0.2206
8 HAEMATOTOXICITY 1948 0.2048
9 MYELOSUPPRESSION 7058 0.1958
See all enriched reactions for Nucleoside Metabolic Inhibitor [EPC]